See under specific drugs. Initially called 'new' antocoagulants: e.g. anti-IIa: dabigatran. Anti-Xa: rivaroxaban, apixaban. Management, reversing agents and antidotes see under PMID 24275169, 27330657. Montitoring of DOAC activity at PMID 27637548. Antidotes and reversal agants at PMID 24275169, 26872887.

Last update : 24/03/2020
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar./airway hemorrhage/bleeding
V - Pleural and/or pericardial involvement
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XVI - Imaging